{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:16:54Z","timestamp":1762604214282,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013142","name":"Translational Science Center, Wake Forest University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011773","name":"Conseil r\u00e9gional de Bourgogne-Franche-Comt\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004711","name":"Chung Hua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejmg.2020.104036","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:22:21Z","timestamp":1597411341000},"page":"104036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation"],"prefix":"10.1016","volume":"63","author":[{"given":"Nawale","family":"Hadouiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Darmency","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Guibaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Arzimanoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Sorlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Carmignac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Huet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Luu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bardou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Thauvin-Robinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Vabres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmg.2020.104036_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022442","article-title":"mTOR signaling in epilepsy: insights from malformations of cortical development","volume":"5","author":"Crino","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10056","key":"10.1016\/j.ejmg.2020.104036_bib2","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejmg.2020.104036_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/fnl-2018-0001","article-title":"The mTOR pathway in treatment of epilepsy: a clinical update","volume":"13","author":"Griffith","year":"2018","journal-title":"Future Neurol. mai"},{"issue":"11","key":"10.1016\/j.ejmg.2020.104036_bib4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejmg.2020.104036_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ejmg.2020.104036_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2013.05.029","article-title":"Role of the mTOR signaling pathway in epilepsy","volume":"332","author":"Meng","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"182","key":"10.1016\/j.ejmg.2020.104036_bib7","doi-asserted-by":"crossref","first-page":"182ra53","DOI":"10.1126\/scitranslmed.3005271","article-title":"Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder","volume":"5","author":"Parker","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.ejmg.2020.104036_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.yebeh.2003.08.012","article-title":"Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients","volume":"4","author":"Sabaz","year":"2003","journal-title":"Epilepsy Behav."},{"issue":"7396","key":"10.1016\/j.ejmg.2020.104036_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11083","article-title":"A unifying model for mTORC1-mediated regulation of mRNA translation","volume":"485","author":"Thoreen","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejmg.2020.104036_bib10","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1073\/pnas.0608510104","article-title":"Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells","volume":"104","author":"Urano","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.ejmg.2020.104036_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-13-0353","article-title":"Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib","volume":"4","author":"Wagle","year":"2014","journal-title":"Canc. Discov."},{"issue":"Suppl. 2","key":"10.1016\/j.ejmg.2020.104036_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/epi.12179","article-title":"Predicting pharmacoresistance in pediatric epilepsy","volume":"54","author":"Wirrell","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ejmg.2020.104036_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2217\/fnl.12.45","article-title":"mTOR as a potential treatment target for epilepsy","volume":"7","author":"Wong","year":"2012","journal-title":"Future Neurol."},{"issue":"3","key":"10.1016\/j.ejmg.2020.104036_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0883073818813238","article-title":"mTOR inhibitors as a New therapeutic Strategy in treatment resistant epilepsy in hemimegalencephaly: a case report","volume":"34","author":"Xu","year":"2019","journal-title":"J Child Neurol."},{"issue":"1","key":"10.1016\/j.ejmg.2020.104036_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721220303724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721220303724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:33:27Z","timestamp":1762558407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721220303724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1769721220303724"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2020.104036","relation":{},"ISSN":["1769-7212"],"issn-type":[{"type":"print","value":"1769-7212"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2020.104036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104036"}}